Fischer Chemic informs about outcome of independent director meet

26 Mar 2022 Evaluate

Pursuant to the provisions of Regulation 25(3) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 and Schedule IV of the Companies Act, 2013, Fischer Chemic has informed that the Independent Director of the Company in their meeting held on Saturday, 26th March, 2022 has: Reviewed the performance of Non-Independent Directors & the Board as a whole, Reviewed the performance of the Chairperson of the company, taking into account the views of Executive Directors and Non-Executive Directors and Assessed the quality, quantity and timeliness of flow of information between the management of the company and the Board.

The above information is a part of company’s filings submitted to BSE.

Fischer Medical Share Price

560.10 -7.80 (-1.37%)
03-Jun-2024 16:01 View Price Chart
Peers
Company Name CMP
Tata Chemicals 1060.50
SRF 2262.00
Pidilite Inds. 2982.00
Aarti Inds 625.10
Gujarat Fluorochemic 3083.00
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.